Aaron Cowen’s Zura Bio ZURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$55.7M Buy
9,443,001
+376,000
+4% +$1.79M 1.02% 28
2026
Q1
$53.9M Buy
9,067,001
+3,500,000
+63% +$21.1M 1.38% 28
2025
Q4
$29.2M Buy
5,567,001
+94,110
+2% +$372K 0.6% 47
2025
Q3
$23.7M Buy
5,472,891
+611,952
+13% +$1.1M 0.61% 50
2025
Q2
$5.1M Hold
4,860,939
0.15% 62
2025
Q1
$6.27M Hold
4,860,939
0.23% 61
2024
Q4
$12.2M Hold
4,860,939
0.41% 53
2024
Q3
$19.7M Hold
4,860,939
0.63% 48
2024
Q2
$17M Buy
4,860,939
+2,010,939
+71% +$8.2M 0.63% 42
2024
Q1
$7.32M Hold
2,850,000
0.27% 57
2023
Q4
$13.3M Hold
2,850,000
0.6% 43
2023
Q3
$18.8M Hold
2,850,000
1.02% 31
2023
Q2
$23.4M Buy
+2,850,000
New +$22.9M 1.25% 29

Other funds holding ZURA

Aaron Cowen's ZURA Position: Q2 2026 in Review

Aaron Cowen increased its Zura Bio (ZURA) stake by 4.1% in Q2 2026, buying an estimated $1.79M and bringing the position to 9,443,001 shares worth $55.7M. The position accounts for 1.02% of the portfolio, ranked #28.

Aaron Cowen first reported a position in ZURA in Q2 2023 and has held it in 13 quarters since. 94 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Aaron Cowen held 9,443,001 shares of Zura Bio worth $55.7M as of Q2 2026.
  • Aaron Cowen bought 376,000 Zura Bio shares in Q2 2026, an estimated $1.79M.
  • Zura Bio made up 1.02% of Aaron Cowen's portfolio in Q2 2026, its #28 holding.
  • Aaron Cowen first reported a position in Zura Bio in Q2 2023 and has held it in 13 quarters since.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Suvretta Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.